CLINICAL GUIDELINE: PART II: Screening for Colorectal Cancer with the Fecal Occult Blood Test: A Background Paper

@inproceedings{Ransohoff1997CLINICALGP,
  title={CLINICAL GUIDELINE: PART II: Screening for Colorectal Cancer with the Fecal Occult Blood Test: A Background Paper},
  author={David F. Ransohoff and C. Lang},
  booktitle={Annals of Internal Medicine},
  year={1997}
}
Colorectal cancer is the second leading cause of cancer-related death in the United States [1]; because of its favorable clinical biology, it is a reasonable target for screening. Data from three randomized clinical trials [2-4] have shown that mortality rates associated with colorectal cancer can be reduced by screening with fecal occult blood tests; other data have shown that such rates can be reduced by screening with sigmoidoscopy [5, 6]. Until recently, authoritative guidelines had… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

Geriatric Medicine

Springer New York • 2003
View 10 Excerpts
Highly Influenced

A comparison of three stool tests for colorectal cancer screening.

Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses • 2005
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 76 references

Long - term risk of rectal and colon cancer after a negative rigid sigmoidoscopy [ Abstract ]

WS Atkin, J Cuzick, R Edwards, JM Northover
Gastroen - terology • 1996

Mass screening: Japanese perspective

H Saito, Y. Yoshida
1996
View 2 Excerpts

Similar Papers

Loading similar papers…